Preventability of Invasive Pneumococcal Disease and Assessment of Current Polysaccharide Vaccine Recommendations for Adults: United States, 2001–2003
Open Access
- 15 July 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (2) , 141-150
Abstract
Background. To prevent Streptococcus pneumoniae infection among persons at highest risk for invasive pneumococcal disease (IPD), the pneumococcal polKeywords
This publication has 17 references indexed in Scilit:
- Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineVaccine, 2005
- Asthma as a Risk Factor for Invasive Pneumococcal DiseaseNew England Journal of Medicine, 2005
- Review of pneumococcal conjugate vaccine in adults: implications on clinical developmentVaccine, 2004
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Effectiveness of Pneumococcal Polysaccharide Vaccine in Older AdultsNew England Journal of Medicine, 2003
- Pneumococcal Vaccination and Revaccination of Older AdultsClinical Microbiology Reviews, 2003
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Cigarette Smoking and Invasive Pneumococcal DiseaseNew England Journal of Medicine, 2000
- Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations1993
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991